ULSC
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Restem, LLC.
Overview
ULSC is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ULSC clinical trials
Explore related
Medical disclaimer. This page summarizes research about ULSC for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.